Ensures that the program is conducted in alignment with CSL Behring processes and abiding by GCP and ICH regulations
Responsible for driving and documenting decision making within the CDT, facilitating issue resolution and escalation, as well as contingency planning
Clinical & Scientific Oversight
Accountable for the clinical content for all CDT deliverables to ensure safe, efficient, timely and quality execution of assigned clinical programs
Ensures high quality clinical and scientific standards are met throughout all aspects of the program
Serves as the clinical development representative on the required cross-functional teams, including but not limited to the Study Execution Team (SET), Safety Management Team (SMT), the Benefit-Risk Assessment Team (BRAT), the Biomarker Expert Team (BET), and the Evidence and Access Strategy Team (EAST) for assigned programs
Develops and executes the Medical Monitoring Plan (MMP) strategy
Typically serves as the medical monitor for clinical trials during study conduct or provides oversight to assigned medical monitors
Presents results to Safety Monitoring Committee and other internal and external meetings
May participate or lead Due Diligence projects in support of CSL’s external innovation efforts
Document Authorship
Reviews the data generated during the planning and execution of a study to gather a clinical understanding of the safety and efficacy results and the impact of the data on ongoing R&D strategies and provides support in defining the development strategy
“Lead Author” or “Contributing” Author for key study documents, including but not limited to: the TPP, PSD, CDP, Study Concept Scenarios, Study Outlines, the Investigator Brochure (IB), Clinical Study Protocols (CSP), Master Informed Consent Forms (ICF), Medical Monitoring Plans (MMP), Safety Review Committee (SRC)/Independent Data Monitoring Committee (IDMC) Charters, and Clinical Study Reports (CSR)
Leads preparations of clinical sections of relevant regulatory interaction packages including but not limited to briefing books, INDs, NDAs. BLAs, ODDs, RFIs, and routine reporting
Contributing author the publication strategy. Author or contributing author for abstracts, presentations, and manuscripts as appropriate
Minimum Qualifications
MD, PhD or PharmD in life science/healthcare discipline expected. MD - Board Certified (or non-USA equivalent) in relevant field is preferred.
5+ years of relevant clinical development experience in the pharmaceutical industry is expected including experience with study data review/evaluation
Clinical development industry experience with a working knowledge of pharmaceutical and regulatory development processes is essential
Demonstrated program leadership capabilities in a matrixed environment
Demonstrated stakeholder management skills including risk mitigation
Proficient in project management terminology and processes to drive clinical development program risk mitigation strategies
Excellent analytical thinking and scientific/medical writing skills
Proficient in clinical data analysis and interpretation
Proven effective problem-solving skills and the ability to think critically and make informed decisions
Demonstrated effective communication and presentation skills
Proven ablility to build bridges and proactively improve cross-functional collaboration
The minimum and maximum base salary range that CSL expects to pay for this position at the Waltham, MA USA work location at the time of this posting is $317,000 - $409,000/yr. Individual base salary for a successful candidate is determined by qualifications, skill level, experience, competencies and other relevant factors. In addition to base salary, total compensation for this role may also include incentive compensation and equity.
#LI-HYBRID
About CSL Behring
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
Our Benefits
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
You Belong at CSL
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging
Equal Opportunity Employer
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.